FDA Inspection 1051652 — KBI Biopharma, Inc.
The FDA completed an inspection of KBI Biopharma, Inc. on April 11, 2018 in Durham, NC. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- April 11, 2018
- Fiscal Year
- 2018
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Durham, NC (United States)